Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2012
News by month February 2012
PTCommunity News February 2012
Drug Treatment Works as Well as Stents
FDA Advisory Panel Recommends Approval of Qnexa for Obesity
Treatment for Patients with Endogenous Cushing’s Syndrome Gains Approval
FDA Acts to Bolster Supply of Critically Needed Cancer Drugs
FDA Reviewers Say Aclidinium Bromide Works, But Concerns About Heart Problems Remain
FDA Approves Zioptan to Treat Elevated Eye Pressure
Counterfeit Version of Avastin Found in United States
New Drug Approved to Treat Glaucoma
NIH Study Shows Benefits of Long-term Kineret Therapy in People with Rare Inflammatory Disease
Scientists Sound Alarm Over Threat of Resistant Gonorrhea
ACP Recommends Metformin as First Medication to Treat Type 2 Diabetes
Screening for Ovarian Cancer Continues, Despite Recommendations to the Contrary
Gleevec Indication Expanded for Use After Surgery to Remove Gastrointestinal Stromal Tumors
